Merck & Co., Inc. news

   Watch this stock
Showing stories 1 - 10 of about 161   

Articles published

MRK 58.95 -0.01 (-0.02%)
price chart
BioPharma Earnings Bracing for Merck, Pfizer, Amgen, Gilead
Pharmaceutical and Biotech investors are about to get a real show for earnings this week. Big Pharma will bring earnings from Dow Jones Industrial Average companies Merck & Co. Inc. (NYSE: MRK) and Pfizer Inc. (NYSE: PFE). Meanwhile biotech investors ...
Earnings Whispers - Merck & Co., Inc. (MRK) To Report Q2 Earnings Today  Bidness ETC
Merck & Co., Inc. (MRK) Releases FY15 Earnings Guidance  Junior College
Large Outflow of Money Witnessed in Merck & Company, Inc.
Merck & Company, Inc. (NYSE:MRK) had an volatile session and gained 0.44 points till last call. The price was at $58.96, gaining 0.75% till the last intraday data.
Morningstar Issues "AA" Credit Rating to Merck & Co. (MRK)  sleekmoney
Merck & Co. Lifted to "Buy" at Zacks (MRK)  Mideast Time
Merck & Co., Inc. - Product Pipeline Review - 2015
This report provides comprehensive information on the current therapeutic developmental pipeline of Merck & Co., Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of ...
ABLYNX SIGNIFICANTLY EXPANDS ITS IMMUNO-ONCOLOGY COLLABORATION WITH MERCK & CO ...
GHENT, Belgium, July 22, 2015 (GLOBE NEWSWIRE) -- Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] today announced an expansion of its immuno-oncology collaboration with a subsidiary of Merck & Co., Inc. ("Merck") [known as MSD outside the United ...
Stocks Beats on Views- Merck & Co. Inc. (NYSE:MRK), CEMEX, SAB de CV (NYSE:CX ...
Merck & Co. Inc. (NYSE:MRK)'s shares traded flat in premarket session on Monday as it vaccine for Ebola is “highly effective,” according to an interim analysis from a panel of experts who recommended that a late-stage trial should continue.
Healthcare Stocks to Track- Exelixis, Inc. (EXEL), Bristol-Myers Squibb Co ...  Techsonian (press release)
Buzz Stocks: NVIDIA Corporation, Merck & Co., Inc., and Medivation Inc
In the options pits, short-term speculators are more put-skewed than usual, per Merck & Co., Inc.'s Schaeffer's put/call open interest ratio (SOIR) of 0.82, which sits higher than 72% of all similar readings taken in the past year.
Merck & Co. Inc. (NYSE:MRK) Cheers To Release Vaccine For Ebola is Highly ...
On the other side, Stocks of Merck & Co. Inc. (NYSE:MRK) increased 0.75% to traded at $58.96 in last session with shares volume of 8.7 Million.
Stock to Follow: Merck & Co Inc (NYSE:MRK)
[Business Wire] Merck & Co Inc (NYSE:MRK)(TREND ANALYSIS) known as MSD outside the United States and Canada, today announced the European Medicines Agency (EMA) has accepted for review a marketing authorization application (MAA) for ...
Merck Announces European Medicines Agency Acceptance of Marketing ...  MarketWatch
Shares of Merck & Company, Inc. (NYSE:MRK) Sees Large Inflow of Net Money Flow
Shares of Merck & Company, Inc. (NYSE:MRK) saw an erosion of -0.02 points in recent session. During the trading, the value of each share was $58.52, dropping -0.03%.
Analyst Consensus Price Target on Merck & Company, Inc. (NYSE:MRK)  Markets Daily
Merck & Co. Upgraded at Zacks (MRK)  Dakota Financial News
Allergan PLC On A Roll; Buys Merck & Co. Migraine Drug Rights
Allergan PLC (NYSE:AGN) announced on Tuesday it has entered into an agreement with Merck & Co., Inc. (NYSE:MRK), under which it would acquire exclusive global rights to two of Merck's migraine drugs currently in experimental stages, MK-1602 and ...
Merck & Co. Inc. (NYSE:MRK) and Allergan plc (AGN) Signs Into an ...  StreetWise Report
Merck & Co., Inc. (NYSE:MRK) Sells Its Migraine Drugs To Allergan PLC ...  USMarketsDaily (blog)